Who Makes Canakinumab? Unveiling the Manufacturer Behind Ilaris
•
3 min read
The medication canakinumab, marketed under the brand name Ilaris®, was first approved by the U.S. Food and Drug Administration (FDA) in June 2009. So, who makes canakinumab? The Swiss multinational healthcare company Novartis is the developer and manufacturer of this important biopharmaceutical.
